530
Views
28
CrossRef citations to date
0
Altmetric
Research Article

The effect of preexisting anti-carrier immunity on subsequent responses to CRM197 or Qb-VLP conjugate vaccines

, , , , , , , , , , , , & show all
Pages 184-196 | Received 20 Nov 2015, Accepted 09 Mar 2016, Published online: 27 Apr 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Henderson Zhu, Christine S. Rollier & Andrew J. Pollard. (2021) Recent advances in lipopolysaccharide-based glycoconjugate vaccines. Expert Review of Vaccines 20:12, pages 1515-1538.
Read now

Articles from other publishers (27)

Milad Kheirvari, Hong Liu & Ebenezer Tumban. (2023) Virus-like Particle Vaccines and Platforms for Vaccine Development. Viruses 15:5, pages 1109.
Crossref
Natalie J. Kingston, Renae Walsh, Rachel Hammond, Carina C. D. Joe, George Lovrecz, Stephen Locarnini & Hans J. Netter. (2023) Immunogenicity of Wild Type and Mutant Hepatitis B Surface Antigen Virus-like Particles (VLPs) in Mice with Pre-Existing Immunity against the Wild Type Vector. Viruses 15:2, pages 313.
Crossref
Rui Shi, Jiawei Zeng, Ling Xu, Fengze Wang, Xiaomin Duan, Yue Wang, Zheng Wu, Dandan Yu, Qingrui Huang, Yong-Gang Yao & Jinghua Yan. (2022) A combination vaccine against SARS-CoV-2 and H1N1 influenza based on receptor binding domain trimerized by six-helix bundle fusion core. eBioMedicine 85, pages 104297.
Crossref
Elena Palmieri, Zoltán Kis, James Ozanne, Roberta Di Benedetto, Beatrice Ricchetti, Luisa Massai, Martina Carducci, Davide Oldrini, Gianmarco Gasperini, Maria Grazia Aruta, Omar Rossi, Cleo Kontoravdi, Nilay Shah, Fatme Mawas & Francesca Micoli. (2022) GMMA as an Alternative Carrier for a Glycoconjugate Vaccine against Group A Streptococcus. Vaccines 10:7, pages 1034.
Crossref
Essie Komla, Oscar B. Torres, Rashmi Jalah, Agnieszka Sulima, Zoltan Beck, Carl R. Alving, Arthur E. Jacobson, Kenner C. Rice & Gary R. Matyas. (2021) Effect of Preexisting Immunity to Tetanus Toxoid on the Efficacy of Tetanus Toxoid-Conjugated Heroin Vaccine in Mice. Vaccines 9:6, pages 573.
Crossref
David F. Zeigler, Emily Gage & Christopher H. Clegg. (2021) Epitope-targeting platform for broadly protective influenza vaccines. PLOS ONE 16:5, pages e0252170.
Crossref
Duško Lainšček, Tina Fink, Vida Forstnerič, Iva Hafner-Bratkovič, Sara Orehek, Žiga Strmšek, Mateja Manček-Keber, Peter Pečan, Hana Esih, Špela Malenšek, Jana Aupič, Petra Dekleva, Tjaša Plaper, Sara Vidmar, Lucija Kadunc, Mojca Benčina, Neža Omersa, Gregor Anderluh, Florence Pojer, Kelvin Lau, David Hacker, Bruno E. Correia, David Peterhoff, Ralf Wagner, Valter Bergant, Alexander Herrmann, Andreas Pichlmair & Roman Jerala. (2021) A Nanoscaffolded Spike-RBD Vaccine Provides Protection against SARS-CoV-2 with Minimal Anti-Scaffold Response. Vaccines 9:5, pages 431.
Crossref
Cyrielle Fougeroux, Louise Goksøyr, Manja Idorn, Vladislav Soroka, Sebenzile K. Myeni, Robert Dagil, Christoph M. Janitzek, Max Søgaard, Kara-Lee Aves, Emma W. Horsted, Sayit Mahmut Erdoğan, Tobias Gustavsson, Jerzy Dorosz, Stine Clemmensen, Laurits Fredsgaard, Susan Thrane, Elena E. Vidal-Calvo, Paul Khalifé, Thomas M. Hulen, Swati Choudhary, Michael Theisen, Susheel K. Singh, Asier Garcia-Senosiain, Linda Van Oosten, Gorben Pijlman, Bettina Hierzberger, Tanja Domeyer, Blanka W. Nalewajek, Anette Strøbæk, Magdalena Skrzypczak, Laura F. Andersson, Søren Buus, Anette Stryhn Buus, Jan Pravsgaard Christensen, Tim J. Dalebout, Kasper Iversen, Lene H. Harritshøj, Benjamin Mordmüller, Henrik Ullum, Line S. Reinert, Willem Adriaan de Jongh, Marjolein Kikkert, Søren R. Paludan, Thor G. Theander, Morten A. Nielsen, Ali Salanti & Adam F. Sander. (2021) Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity. Nature Communications 12:1.
Crossref
Sharareh Eskandari, Michael F. Good & Manisha Pandey. 2021. Peptide Conjugation. Peptide Conjugation 17 33 .
Christine Robinson, Valeria Gradinati, Fatima Hamid, Carly Baehr, Bethany Crouse, Saadyah Averick, Marina Kovaliov, Danni Harris, Scott Runyon, Federico Baruffaldi, Mark LeSage, Sandra Comer & Marco Pravetoni. (2020) Therapeutic and Prophylactic Vaccines to Counteract Fentanyl Use Disorders and Toxicity. Journal of Medicinal Chemistry 63:23, pages 14647-14667.
Crossref
Wenbo Jiang, Emily H. Pilkington, Hannah G. Kelly, Hyon-Xhi Tan, Jennifer A. Juno, Adam K. Wheatley & Stephen J. Kent. (2020) Aggregation by peptide conjugation rescues poor immunogenicity of the HA stem. PLOS ONE 15:11, pages e0241649.
Crossref
Qiuyang Huang, Qian Gao, Xiaoxin Chai, Wei Ren, Guifeng Zhang, Yingjun Kong, Yan Zhang, Jianping Gao, Xiongxin Lei & Li Ma. (2020) A novel thrombin inhibitory peptide discovered from leech using affinity chromatography combined with ultra-high performance liquid chromatography-high resolution mass spectroscopy. Journal of Chromatography B 1151, pages 122153.
Crossref
Kyle Saylor, Frank Gillam, Taylor Lohneis & Chenming Zhang. (2020) Designs of Antigen Structure and Composition for Improved Protein-Based Vaccine Efficacy. Frontiers in Immunology 11.
Crossref
Joan Kha-Tu Ho, Beena Jeevan-Raj & Hans-Jürgen Netter. (2020) Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms. Viruses 12:2, pages 126.
Crossref
Rashi Yadav, Lukai Zhai & Ebenezer Tumban. (2019) Virus-like Particle-Based L2 Vaccines against HPVs: Where Are We Today?. Viruses 12:1, pages 18.
Crossref
Arianna Marini, Yu Zhou, Yuanyuan Li, Iona J. Taylor, Darren B. Leneghan, Jing Jin, Marija Zaric, David Mekhaiel, Carole A. Long, Kazutoyo Miura & Sumi Biswas. (2019) A Universal Plug-and-Display Vaccine Carrier Based on HBsAg VLP to Maximize Effective Antibody Response. Frontiers in Immunology 10.
Crossref
David F. Zeigler, Emily Gage, Richard Roque & Christopher H. Clegg. (2019) Epitope targeting with self-assembled peptide vaccines. npj Vaccines 4:1.
Crossref
Lv-Xia DaiJing YangJian-Min LiuSizhou HuangBao-Ning WangHong LiJie YangZhong-Yi ZhaoKang CaoMing-Yuan Li. (2019) Adenovirus-Mediated CRM197 Sensitizes Human Glioma Cells to Gemcitabine by the Mitochondrial Pathway. Cancer Biotherapy and Radiopharmaceuticals 34:3, pages 171-180.
Crossref
David F. Zeigler, Richard Roque & Christopher H. Clegg. (2019) Optimization of a multivalent peptide vaccine for nicotine addiction. Vaccine 37:12, pages 1584-1590.
Crossref
S. Barbosa Méndez & A. Salazar-Juárez. (2018) Current status of nicotine vaccines: A narrative review. Vacunas (English Edition) 19:2, pages 67-78.
Crossref
S. Barbosa Méndez & A. Salazar-Juárez. (2018) Estado actual de las vacunas contra la nicotina: una revisión narrativa. Vacunas 19:2, pages 67-78.
Crossref
Atsushi Kimishima, Margaret E. Olson, Yoshihiro Natori & Kim D. Janda. (2018) Efficient Syntheses of Cocaine Vaccines and Their in Vivo Evaluation . ACS Medicinal Chemistry Letters 9:5, pages 411-416.
Crossref
Janice E. Sieser, Mark T. Maloney, Esmort Chisowa, Steven J. Brenek, Sebastien Monfette, John J. Salisbury, Nga M. Do & Robert A. Singer. (2018) Ir-Catalyzed Borylation as an Efficient Route to a Nicotine Hapten. Organic Process Research & Development 22:4, pages 527-534.
Crossref
Chi-Jiun Peng, Hsiu-Ling Chen, Cheng-Hsun Chiu & Jim-Min Fang. (2018) Site-Selective Functionalization of Flagellin by Steric Self-Protection: A Strategy To Facilitate Flagellin as a Self-Adjuvanting Carrier in Conjugate Vaccine. ChemBioChem 19:8, pages 805-814.
Crossref
Mohamed Tashani, Leon Heron, Melanie Wong, Harunor Rashid & Robert Booy. (2017) Tetanus–diphtheria–pertussis vaccine may suppress the immune response to subsequent immunization with pneumococcal CRM197-conjugate vaccine (coadministered with quadrivalent meningococcal TT-conjugate vaccine): a randomized, controlled trial⋆. Journal of Travel Medicine 24:4.
Crossref
Falk Saupe, Matthias Reichel, Elisabeth J. M. Huijbers, Julia Femel, Per-Olof Markgren, C. Evalena Andersson, Sebastian Deindl, U. Helena Danielson, Lars T. Hellman & Anna-Karin Olsson. (2016) Development of a novel therapeutic vaccine carrier that sustains high antibody titers against several targets simultaneously. The FASEB Journal 31:3, pages 1204-1214.
Crossref
Atsushi Kimishima, Cody J. Wenthur, Bin Zhou & Kim D. Janda. (2016) An Advance in Prescription Opioid Vaccines: Overdose Mortality Reduction and Extraordinary Alteration of Drug Half-Life. ACS Chemical Biology 12:1, pages 36-40.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.